Twist Bioscience Corp. (TWST)
135.16
+14.37
(+11.90%)
USD |
NASDAQ |
Nov 09, 16:00
135.01
-0.15
(-0.11%)
After-Hours: 19:15
Twist Bioscience Total Return Level : 120.79 for Nov. 6, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 06, 2026 | 120.79 |
| November 05, 2026 | 120.61 |
| November 04, 2026 | 142.58 |
| November 03, 2026 | 140.30 |
| November 02, 2026 | 129.04 |
| October 30, 2026 | 152.78 |
| October 29, 2026 | 173.45 |
| October 28, 2026 | 173.45 |
| October 27, 2026 | 159.85 |
| October 26, 2026 | 145.25 |
| October 23, 2026 | 139.92 |
| October 22, 2026 | 135.47 |
| October 21, 2026 | 149.13 |
| October 20, 2026 | 142.70 |
| October 19, 2026 | 139.77 |
| October 16, 2026 | 132.75 |
| October 15, 2026 | 144.49 |
| October 14, 2026 | 148.16 |
| October 13, 2026 | 151.33 |
| October 12, 2026 | 151.86 |
| October 09, 2026 | 159.78 |
| October 08, 2026 | 152.05 |
| October 07, 2026 | 155.65 |
| October 06, 2026 | 166.97 |
| October 05, 2026 | 205.00 |
| Date | Value |
|---|---|
| October 02, 2026 | 188.67 |
| October 01, 2026 | 188.05 |
| September 30, 2026 | 193.24 |
| September 29, 2026 | 186.13 |
| September 28, 2026 | 179.60 |
| September 25, 2026 | 182.83 |
| September 24, 2026 | 184.03 |
| September 23, 2026 | 158.50 |
| September 22, 2026 | 164.60 |
| September 21, 2026 | 165.83 |
| September 18, 2026 | 166.99 |
| September 17, 2026 | 155.56 |
| September 16, 2026 | 143.07 |
| September 15, 2026 | 138.10 |
| September 14, 2026 | 134.75 |
| September 11, 2026 | 127.22 |
| September 10, 2026 | 126.85 |
| September 09, 2026 | 125.52 |
| September 08, 2026 | 128.06 |
| September 04, 2026 | 124.72 |
| September 03, 2026 | 128.71 |
| September 02, 2026 | 131.00 |
| September 01, 2026 | 132.06 |
| August 31, 2026 | 139.00 |
| August 28, 2026 | 141.38 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Intellia Therapeutics, Inc. | 11.35 |
| Beam Therapeutics, Inc. | 26.41 |
| 10X Genomics, Inc. | 59.28 |
| Moderna, Inc. | 254.19 |
| Prime Medicine, Inc. | 4.65 |